A Prescription for Successful Collaborations – Week 4

The problem with collaboration is that there is a lot to them.  They require work, real effort and a steely determination to succeed.  Through this series, I want to expose you to the challenges and ask you to consider the actions you might take to optimise the benefit of collaborative partnerships.  I am asking you to take the Prescription for Successful Collaborations and see the benefit it will bring you.

So far, we have covered four of the seven key points. This week, I will cover two more.

Agree a single Source of Truth

The ability to harness vast and often conflicting datasets is crucial for driving innovation and making informed decisions. Establishing a single source of truth is essential to ensure consistency, validity, reliability, regulatory confidence, and efficiency to drive more cost-effective and innovative outcomes.

A single source of truth ensures that all stakeholders in collaboration access and work from the same data, minimizing discrepancies and enhancing trust. In an industry where data integrity can significantly impact patient outcomes, having a unified data source is not just beneficial—it’s vital.

In the collaboration between Merck and AstraZeneca on a combination therapy for cancer, they maintained a single source of truth, and both companies were able to streamline their research processes, reduce redundancy, and enhance accuracy.

Go Beyond Traditional Skills

Successful collaboration hinges on the careful selection of team members. The synergy created through effective teamwork often leads to breakthroughs that would be unattainable individually. However, this synergy can be disrupted by individuals who are more self-oriented than team-oriented. Understanding the impact of these dynamics and strategically forming teams can significantly enhance collaboration outcomes.

A study published in 2006 in Research in Organisational Behaviour revealed the detrimental effects of including self-oriented individuals in teams, whilst a 2022 study by researchers from the University of Groningen underscores the importance of meritocratic matching, which involves selecting team members based on their cooperative behaviours rather than just availability or skill sets.

Pharmaceutical collaborations require high levels of cooperation and trust due to the complexity and stakes involved. The I-SPY 2 trial, a collaborative effort in breast cancer research, exemplifies the benefits of a well-coordinated team.
 

What you could do this week:

Two actions for you to consider this week:

• Are you investing sufficiently in advanced data management technologies that ensure data is collected, stored, and processed consistently across all platforms?
• Evaluate potential team members based on prosocial behaviours rather than relying solely on self-reports or past affiliations.

Tricordant is here to support you where you may need it as you navigate the journey through these points.  Get in touch if you need some support or want to have a conversation.  Remember, there is more information on our website in the blogs I have written on this subject. (Click here)